nature.com search

Loading Filters

Showing 1–23 of 23 results

Loading Filters

Amendments and Corrections | 4 March 2002
Erratum: Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expression
- V Deneys
- , L Michaux
- , P Leveugle
- , AM Mazzon
- , E Gillis
- , A Ferrant
- , JM Scheiff
- & M De Bruyère
Leukemia 16 , 402–402

Rights & permissionsfor article Erratum: Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expression . Opens in a new window.
28 September 2001
Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expression
- V Deneys
- , L Michaux
- , P Leveugle
- , AM Mazzon
- , E Gillis
- , A Ferrant
- , JM Scheiff
- & M De Bruyère
Leukemia 15 , 1458–1465

Rights & permissionsfor article Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expression . Opens in a new window.
28 October 2004
Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in ‘unmutated’ B-CLL
- L Michaux
- , I Wlodarska
- , K Rack
- , M Stul
- , A Criel
- , M Maerevoet
- , S Marichal
- , H Demuynck
- , P Mineur
- , K Kargar Samani
- , A Van Hoof
- , A Ferrant
- , P Marynen
- & A Hagemeijer
Leukemia 19 , 77–82

Rights & permissionsfor article Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in ‘unmutated’ B-CLL . Opens in a new window.
Research | 12 February 2009
FIP1L1-PDGFRα D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRα T674I eosinophilic leukemia with single agent sorafenib
- E Lierman
- , L Michaux
- , E Beullens
- , P Pierre
- , P Marynen
- , J Cools
- & P Vandenberghe
Leukemia 23 , 845–851

Rights & permissionsfor article FIP1L1-PDGFRα D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRα T674I eosinophilic leukemia with single agent sorafenib . Opens in a new window.
24 May 2007
Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL
- H Pospisilova
- , M Baens
- , L Michaux
- , M Stul
- , P Van Hummelen
- , P Van Loo
- , J Vermeesch
- , M Jarosova
- , Z Zemanova
- , K Michalova
- , I Van den Berghe
- , H D Alexander
- , A Hagemeijer
- , P Vandenberghe
- , J Cools
- , C De Wolf-Peeters
- , P Marynen
- & I Wlodarska
Leukemia 21 , 2079–2083

Rights & permissionsfor article Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL . Opens in a new window.
Research | 5 November 1960
Glucose 6-phosphate Dehydrogenase Deficiency, Haptoglobin Groups, Blood Groups and Sickle Cell Trait in the Bantus of West Belgian Congo
- J. SONNET
- & J. L. MICHAUX
Nature 188 , 504–505

Rights & permissionsfor article Glucose 6-phosphate Dehydrogenase Deficiency, Haptoglobin Groups, Blood Groups and Sickle Cell Trait in the Bantus of West Belgian Congo . Opens in a new window.
18 February 2003
Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with Imatinib
- P Meeus
- , H Demuynck
- , Ph Martiat
- , L Michaux
- , E Wouters
- & A Hagemeijer
Leukemia 17 , 465–467

Rights & permissionsfor article Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with Imatinib . Opens in a new window.
Correspondence | 30 August 2002
The novel t(11;12;18)(q21;q13;q21) represents a variant translocation of the t(11;18)(q21;q21) associated with MALT-type lymphoma
- J Dierlamm
- , EM Murga Penas
- , M Daibata
- , H Tagushi
- , K Hinz
- , M Baens
- , J Cools
- , G Schilling
- , L Michaux
- , P Marynen
- , I Miyoshi
- & DK Hossfeld
Leukemia 16 , 1863–1864

Rights & permissionsfor article The novel t(11;12;18)(q21;q13;q21) represents a variant translocation of the t(11;18)(q21;q21) associated with MALT-type lymphoma . Opens in a new window.
9 June 2005
FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations
- I Wlodarska
- , E Veyt
- , P De Paepe
- , P Vandenberghe
- , P Nooijen
- , I Theate
- , L Michaux
- , X Sagaert
- , P Marynen
- , A Hagemeijer
- & C De Wolf-Peeters
Leukemia 19 , 1299–1305

Rights & permissionsfor article FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations . Opens in a new window.
19 March 2009
Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia
- N Put
- , P Meeus
- , B Chatelain
- , K Rack
- , N Boeckx
- , F Nollet
- , C Graux
- , E Van Den Neste
- , A Janssens
- , V Madoe
- , A Van Hoof
- , C Bilhou-Nabera
- , I Wlodarska
- , P Vandenberghe
- & L Michaux
Leukemia 23 , 1201–1204

Rights & permissionsfor article Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia . Opens in a new window.
Research | 12 September 2004
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia
- C. Graux
- , J. Cools
- , C. Melotte
- , H. Quentmeier
- , A. Ferrando
- , R. Levine
- , J.R. Vermeesch
- , M. Stul
- , B. Dutta
- , N. Boeckx
- , A. Bosly
- , P. Heimann
- , A. Uyttebroeck
- , N. Mentens
- , R. Somers
- , R.A.F. MacLeod
- , H.G. Drexler
- , A.T. Look
- , D.G. Gilliland
- , L. Michaux
- , P. Vandenberghe
- , I. Wlodarska
- , Peter Marynen
- & Anne Hagemeijer
Nature Genetics 36 , 1084–1089

Rights & permissionsfor article Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia . Opens in a new window.
10 September 2003
t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH)
- R Berger
- , N Dastugue
- , M Busson
- , J van den Akker
- , C Pérot
- , P Ballerini
- , A Hagemeijer
- , L Michaux
- , C Charrin
- , M P Pages
- , F Mugneret
- , J Andrieux
- , P Talmant
- , C Hélias
- , L Mauvieux
- , M Lafage-Pochitaloff
- , M-J Mozziconacci
- , P Cornillet-Lefebvre
- , I Radford
- , V Asnafi
- , C Bilhou-Nabera
- , F Nguyen Khac
- , C Léonard
- , F Speleman
- , B Poppe
- , C Bastard
- , S Taviaux
- , B Quilichini
- , C Herens
- , M-J Grégoire
- , H Cavé
- & O A Bernard
Leukemia 17 , 1851–1857

Rights & permissionsfor article t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH) . Opens in a new window.
15 April 2004
Translocation t(2;3)(p15–23;q26–27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features
- M Stevens-Kroef
- , B Poppe
- , S van Zelderen-Bhola
- , E van den Berg
- , M van der Blij-Philipsen
- , A Geurts van Kessel
- , R Slater
- , G Hamers
- , L Michaux
- , F Speleman
- & A Hagemeijer
Leukemia 18 , 1108–1114

Rights & permissionsfor article Translocation t(2;3)(p15–23;q26–27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features . Opens in a new window.
19 February 2004
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias
- P Vandenberghe
- , I Wlodarska
- , L Michaux
- , P Zachée
- , M Boogaerts
- , D Vanstraelen
- , M-C Herregods
- , A Van Hoof
- , D Selleslag
- , F Roufosse
- , M Maerevoet
- , G Verhoef
- , J Cools
- , D G Gilliland
- , A Hagemeijer
- & P Marynen
Leukemia 18 , 734–742

Rights & permissionsfor article Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias . Opens in a new window.
2 October 2008
MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients
- Ev Stralen
- , R J Leguit
- , H Begthel
- , L Michaux
- , A Buijs
- , H Lemmens
- , J M Scheiff
- , C Doyen
- , P Pierre
- , F Forget
- , H C Clevers
- & BJEG Bast
Leukemia 23 , 801–803

Rights & permissionsfor article MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients . Opens in a new window.
18 December 2000
IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes
- L Dumoutier
- , E Van Roost
- , G Ameye
- , L Michaux
- & J-C Renauld
Genes and Immunity 1 , 488–494

Rights & permissionsfor article IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes . Opens in a new window.
Research | 31 May 2007
Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine
- E Van Den Neste
- , V Robin
- , J Francart
- , A Hagemeijer
- , M Stul
- , P Vandenberghe
- , A Delannoy
- , A Sonet
- , V Deneys
- , S Costantini
- , A Ferrant
- , A Robert
- & L Michaux
Leukemia 21 , 1715–1722

Rights & permissionsfor article Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine . Opens in a new window.
6 June 2000
Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma
- E Van Den Neste
- , I Louviaux
- , JL Michaux
- , A Delannoy
- , L Michaux
- , A Sonet
- , A Bosly
- , C Doyen
- , P Mineur
- , M André
- , N Straetmans
- , E Coche
- , C Venet
- , T Duprez
- & A Ferrant
Leukemia 14 , 1136–1142

Rights & permissionsfor article Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma . Opens in a new window.
Research | 2 December 2016
RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response
- I J F Hofman
- , M van Duin
- , E De Bruyne
- , L Fancello
- , G Mulligan
- , E Geerdens
- , E Garelli
- , C Mancini
- , H Lemmens
- , M Delforge
- , P Vandenberghe
- , I Wlodarska
- , A Aspesi
- , L Michaux
- , K Vanderkerken
- , P Sonneveld
- & K De Keersmaecker
Leukemia 31 , 1706–1714

Rights & permissionsfor article RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response . Opens in a new window.
1 May 1997
Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization
- J Dierlamm
- , C Rosenberg
- , M Stul
- , S Pittaluga
- , I Wlodarska
- , L Michaux
- , M Dehaen
- , G Verhoef
- , J Thomas
- , W de Kelver
- , T Bakker-Schut
- , JJ Cassiman
- , AK Raap
- , C De Wolf-Peeters
- , H Van den Berghe
- & A Hagemeijer
Leukemia 11 , 747–758

Rights & permissionsfor article Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization . Opens in a new window.
6 July 2006
Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast
- C Graux
- , J Cools
- , L Michaux
- , P Vandenberghe
- & A Hagemeijer
Leukemia 20 , 1496–1510

Rights & permissionsfor article Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast . Opens in a new window.
Research | 16 October 2008
Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia
- C Graux
- , M Stevens-Kroef
- , M Lafage
- , N Dastugue
- , C J Harrison
- , F Mugneret
- , K Bahloula
- , S Struski
- , M J Grégoire
- , N Nadal
- , E Lippert
- , S Taviaux
- , A Simons
- , R P Kuiper
- , A V Moorman
- , K Barber
- , A Bosly
- , L Michaux
- , P Vandenberghe
- , I Lahortiga
- , K De Keersmaecker
- , I Wlodarska
- , J Cools
- , A Hagemeijer
- & H A Poirel
Leukemia 23 , 125–133

Rights & permissionsfor article Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia . Opens in a new window.
Research | 10 May 2007
A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation
- J I Martín-Subero
- , R Ibbotson
- , W Klapper
- , L Michaux
- , E Callet-Bauchu
- , F Berger
- , M J Calasanz
- , C De Wolf-Peeters
- , M J Dyer
- , P Felman
- , A Gardiner
- , R D Gascoyne
- , S Gesk
- , L Harder
- , D E Horsman
- , M Kneba
- , R Küppers
- , A Majid
- , N Parry-Jones
- , M Ritgen
- , M Salido
- , F Solé
- , G Thiel
- , H-H Wacker
- , D Oscier
- , I Wlodarska
- & R Siebert
Leukemia 21 , 1532–1544

Rights & permissionsfor article A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation . Opens in a new window.

Refine your results by…

Filters

Filter By:

Erratum: Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expression

Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expression

Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in ‘unmutated’ B-CLL

FIP1L1-PDGFRα D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRα T674I eosinophilic leukemia with single agent sorafenib

Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL

Glucose 6-phosphate Dehydrogenase Deficiency, Haptoglobin Groups, Blood Groups and Sickle Cell Trait in the Bantus of West Belgian Congo

Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with Imatinib

The novel t(11;12;18)(q21;q13;q21) represents a variant translocation of the t(11;18)(q21;q21) associated with MALT-type lymphoma

FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations

Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH)

Translocation t(2;3)(p15–23;q26–27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features

Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias

MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients

IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes

Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine

Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma

RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response

Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization

Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast

Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia

A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters